More than three years after Gilead Sciences’ hepatitis D drug bulevirtide was rebuffed by the FDA due to manufacturing and delivery concerns, the treatment has since redeemed itself by scoring a green ...

A multi-billion-dollar acquisition within the radiopharmaceutical space could be percolating as Lantheus Holding considers a ...

Korea’s SK bioscience has signed a technology transfer and manufacturing deal with the Colombian government which will allow ...

After striking radiopharmaceutical supply deals with pharma giants Novartis and AstraZeneca within the last six months, Niowave is taking steps to meet growing demand for the alpha-emitting isotope ...

Emerging pharma companies face growing pressure to scale quickly while managing lean teams, limited resources and rising expectations around agentic AI. In this episode of The Top Line, Fierce Biotech ...

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence, announcing a sweeping agreement with Anthropic to deploy its AI tool Claude as the “shared ...

Gilead Sciences and the World Health Organization (WHO) are doubling down on a pact to eliminate deadly parasitic disea | ...

AbbVie's 85 layoffs are tied to its Allergan Aesthetics headquarters in California, while Novartis is cutting more staff at ...

Healthcare agencies remain at the forefront of pharmaceutical marketing, but new technologies and shifting political dynamics ...

A web of mail-order pharmacies, wholesalers and patient services groups connected to the self-styled largest Pentecostal ...

A year after a major layoff round at its Allergan headquarters in California, AbbVie is making more edits to its workforce with a new round of 85 layoffs.  | The layoffs at AbbVie's Irvine, California ...